TriSalus Life Sciences (TLSI) Cash & Current Investments (2022 - 2025)
Historic Cash & Current Investments for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $22.7 million.
- TriSalus Life Sciences' Cash & Current Investments rose 10098.33% to $22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.7 million, marking a year-over-year increase of 10098.33%. This contributed to the annual value of $8.5 million for FY2024, which is 2761.31% down from last year.
- As of Q3 2025, TriSalus Life Sciences' Cash & Current Investments stood at $22.7 million, which was up 10098.33% from $26.5 million recorded in Q2 2025.
- Over the past 5 years, TriSalus Life Sciences' Cash & Current Investments peaked at $26.5 million during Q2 2025, and registered a low of $50930.0 during Q1 2022.
- In the last 4 years, TriSalus Life Sciences' Cash & Current Investments had a median value of $9.4 million in 2022 and averaged $9.7 million.
- Data for TriSalus Life Sciences' Cash & Current Investments shows a peak YoY increase of 1575092.57% (in 2024) and a maximum YoY decrease of 4721.04% (in 2024) over the last 5 years.
- Over the past 4 years, TriSalus Life Sciences' Cash & Current Investments (Quarter) stood at $9.4 million in 2022, then rose by 25.1% to $11.8 million in 2023, then fell by 27.61% to $8.5 million in 2024, then surged by 166.12% to $22.7 million in 2025.
- Its last three reported values are $22.7 million in Q3 2025, $26.5 million for Q2 2025, and $13.0 million during Q1 2025.